- USD/INR reverses the previous day’s losses, refresh intraday high.
- ADB cuts India’s FY22 GDP forecast, Indian parliament jostles over 1.87 lack crore stimulus.
- Indian markets are closed, virus updates, US infrastructure voting in focus.
USD/INR prints mild gains around 74.60 even Indian markets are off on Wednesday. In doing so, the Indian rupee (INR) justifies the covid woes at home and abroad while also adhering to the US dollar strength.
That said, the US Dollar Index (DXY) prints a five-day uptrend around April tops, up 0.06% intraday around 93.02 by the press time, as Delta covid variant weighs on market sentiment. Also putting a safe-haven bid under the greenback could be the Sino-American tussles. Additionally, hopes of further stimulus from US President Joe Biden also back the US Dollar bulls.
While slower jabbing has already put Australia at economic risk, India is also struggling as far as vaccinations are concerned. On Tuesday, an Indian Government official said, “one-in-three vulnerable to getting infected to covid-19.”
Also negative for the INR is the deadlock over 1.87 lakh crore stimulus in the Indian parliament as a routine drama in the house stopped negotiations ahead of today’s holiday.
As a result, the Asian Development Bank (ADB) cuts the Asian nation’s FY 2022 GDP forecast to 10% versus 11% expected earlier.
Elsewhere, comments from US Deputy Secretary of State Wendy Sherman also amplifies the risk-off mood and back the USD as the diplomat raises concerns over North Korea and China during the trilateral meet in Tokyo.
Amid these plays, US 10-year Treasury yields fade bounce off February lows whereas stocks in Asia-Pacific attempts a recovery.
Although the Indian holiday may restrict the USD/INR moves, the broad US dollar strength could keep the pair buyers hopeful. It’s worth noting that the US Senate’s procedural voting on the infrastructure spending bill will be the key while covid updates and Sino-American tension, not to forget the Indian political news, can act as extra catalysts.
Unless offering a daily close below 74.50-45 area, comprising 21-day SMA and monthly support line, USD/INR sellers remain incapable of taking the controls.
Additional important levels
|Today last price||74.6054|
|Today Daily Change||0.0652|
|Today Daily Change %||0.09%|
|Today daily open||74.5402|
|Previous Daily High||75.0006|
|Previous Daily Low||74.5337|
|Previous Weekly High||74.8515|
|Previous Weekly Low||74.4034|
|Previous Monthly High||74.5135|
|Previous Monthly Low||72.4854|
|Daily Fibonacci 38.2%||74.7121|
|Daily Fibonacci 61.8%||74.8223|
|Daily Pivot Point S1||74.3824|
|Daily Pivot Point S2||74.2246|
|Daily Pivot Point S3||73.9154|
|Daily Pivot Point R1||74.8493|
|Daily Pivot Point R2||75.1585|
|Daily Pivot Point R3||75.3163|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.